期刊文献+

瑞舒伐他汀和替米沙坦对原发性高血压并发阵发性心房纤颤治疗的影响

Effects of rosuvastatin and telmisartan on patients with essential hypertension with paroxysmal atrial fibrillation
原文传递
导出
摘要 目的:观察瑞舒伐他汀和替米沙坦对原发性高血压(EH)并发阵发性心房纤颤(AF)患者心电图P波时限和离散度及AF发生率的影响。方法:EH并发阵发性AF患者56例,随机分为2组:替米沙坦(80 mg/d)加瑞舒伐他汀(10 mg/d)组(联合用药组)和替米沙坦(80 mg/d)组。共观察6个月。分别于用药前后测定12导联体表心电图中P波的时限和P波离散度及AF发生率。结果:用药后两组均可使EH并发阵发性EH患者心电图P波的时限和P波离散度减小,组间比较显示,联合用药组的作用优于单用替米沙坦组。结论:瑞舒伐他汀合用替米沙坦对EH并发阵发性AF患者窦律的维持及预防AF发生的作用优于单用替米沙坦。 AIM:To study the effects of rosuvastatin and telmisartan on P-wave dispersion in eletrocardiography in patients with essential hypertension(EH).METHODS:Fifty-six patients were randomly divided into telmisartan(80 mg/day) plus rosuvastatin(10 mg/day) group and telmisartan(80 mg/day) group and were monitored for 6 months.P-wave duration and P-wave dispersion were detected before and after using the drugs.RESULTS:After using the drugs,P-wave duration and P-wave dispersion in both groups of patients with EH decreased(P0.05).Compared with telmisartan alone,rosuvastatin plus telmisartan had more obvious effect on P-wave dispersion.CONCLUSION:Treatment with rosuvastatin and telmisartan has more effective value in preventing atrial fibrillation than using telmisartan only in patients with EH.
出处 《心脏杂志》 CAS 2012年第1期54-56,共3页 Chinese Heart Journal
关键词 高血压 原发性 心房纤颤 瑞舒伐他汀 替米沙坦 P波离散度 essential hypertension atrial fibrillation rosuvastatin telmisartan P-wave dispersion
  • 相关文献

参考文献8

二级参考文献35

  • 1田静文,方颖,周爱英.急性冠脉综合征初期他汀类药物短期治疗对内皮功能的影响[J].中国药业,2004,13(12):65-67. 被引量:25
  • 2Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广(译),王淑敏(译),胡大一(校).极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志(中文版),2006,25(4):215-223. 被引量:349
  • 3王继征,张国清,阚国庆,王凤,李广军.阿托伐他汀改善高血压合并2型糖尿病患者颈动脉粥样硬化[J].中华高血压杂志,2006,14(10):789-792. 被引量:10
  • 4瑞舒伐他汀中国注册临床研究协作组,高润霖,祁哲,杨宏.瑞舒伐他汀治疗中国高胆固醇血症患者疗效和安全性的随机双盲多中心对照研究[J].中华心血管病杂志,2007,35(3):207-211. 被引量:122
  • 5Dilaveris PE, Gialatos EJ, Chrissos D, et al. Detection of hypertensive patients at risk for paroxysmal atrial fibrillation during sinus rhythm by computer-assisted P wave analysis [ J ]. J Hypertens, 1999, 17 (10) : 1463 - 1470.
  • 6Nakashima H, Kumagai K, Urata H, et al. Angiotensin Ⅱ antagonist prevents electrical remodeling in atrial fibrillation [ J ]. Circulation, 2000, 101 (22) :2612 -2617.
  • 7Madrid AH, Bueno MG, Rebollo JM, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation. :aprospective and randomized study [ J ]. Circulation, 2002, 106 ( 3 ) :331 - 336.
  • 8Lopez B, Querejeta R, Varo N, et al. Usefulness of eardioreparative ability of antihypertensive treatment in hypertensive patients [ J ]. Circulation, 2001, 104 ( 3 ) : 286 - 291.
  • 9Mitchell AR, Spurrell PA, Sulke N. Circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation[ J]. Am Heart J, 2003, 146(5 ) :902 -907.
  • 10Ciaroni S, Cuenoud L, Bloch A. Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension[J]. Am Heart J, .2000, 139(5):814-819.

共引文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部